Cargando…
LINC00324 in cancer: Regulatory and therapeutic implications
LINC00324 is a 2082 bp intergenic noncoding RNA. Aberrant expression of LINC00324 was associated with the risk of 11 tumors and was closely associated with clinicopathological features and prognostic levels of 7 tumors. LINC00324 can sponge multiple miRNAs to form complex ceRNA networks, and can als...
Autores principales: | Xia, Qing, Shen, Jinze, Wang, Qurui, Ke, Yufei, Yan, Qibin, Li, Hanbing, Zhang, Dayong, Duan, Shiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815511/ https://www.ncbi.nlm.nih.gov/pubmed/36620587 http://dx.doi.org/10.3389/fonc.2022.1039366 |
Ejemplares similares
-
Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis
por: Shen, Jinze, et al.
Publicado: (2022) -
Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study
por: Sharma, Uttam, et al.
Publicado: (2022) -
Novel Insights into miR-944 in Cancer
por: Shen, Jinze, et al.
Publicado: (2022) -
LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
por: Zhong, Chenming, et al.
Publicado: (2022) -
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
por: Shen, Jinze, et al.
Publicado: (2023)